Research

Topics Publications In progress publications Communications

Packages

AnaQol Project PRO-online R Packages Online R-package

Life of the unit

Projects Collaborations PhD thesis Traineeships Traineeships propositions Seminars

Next seminars

25 juin 2018 Bénédicte Sautenet Identifying patient-important outcomes in polycystic kidney disease: an international nominal group technique study

Last publications

06 juin 2018 Tessier P, Thuilliez J (2018) Does freedom make a difference? : An empirical investigation of differences between subjective well-being and perceived capabilities amongst cancer patients.. The European Journal of Health Economics: .

06 juin 2018 Vergnaud S, Riche VP, Tessier P, Mauduit N, Kaladji A, Gouëffic Y (2018) Budget impact analysis of heparin-bonded polytetrafluoroethylene grafts (Propaten) against standard polytetrafluoroethylene grafts for below-the-knee bypass in patients with critical limb ischaemia in France. BMJ Open, 8(2): .

15 mai 2018 Nadal M, Levy M, Bakhsh A, Joly A, Maruani A, Vaillant L, Erra B, Samimi M (2018) Salivary scintigraphy for Sjögren's syndrome in patients with xerostomia: A retrospective study. Oral Dis, 24(4): 552-60.

15 mai 2018 Viecelli A, Tong A, O'Lone E, Ju A, Hanson C, Sautenet B, Craig J, Manns B, Howell M, Chemla E, Hooi L, Johnson D, Lee T, Lok C, Polkinghorne K, Quinn R, Vachharajani T, Vanholder R, Zuo L, Hawley C, SONG-HD Vascular Access Workshop Investigators (2018) Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access. Am J Kidney Dis, 71(5): 690-700.

02 mai 2018 Le Cornec C, Lariby S, Brenckmann V, Hardouin JB, Ecoffey C, Le pottier M, Fraddin P, Broch H, Kabbaj A, Auffret Y, Deciron F, Longo C, Javaudin F, Le Bastard O, Jenvrin J, Montassier E (2018) Is intravenously administered, subdissociative-dose KETAmine non-inferior to MORPHine for prehospital analgesia (the KETAMORPH study): study protocol for a randomized controlled trial. Trials, 19(1): 260.

Updated

20 juin 2018

Annie-Pierre Jonville-Bera

Situation

Poste : PH Pharmacologie
Institution : CHU de Tours

Publications scientifiques

Articles dans une revue internationale

1. Cornillier H, Giraudeau B, Munck S, Hacard F, Jonville-Bera AP, d'Acremont G, Pham B, Maruani A (2018) Chronic spontaneous urticaria in children - a systematic review on interventions and comorbidities. Pediatr Allergy Immunol: Epub ahead of print.
2. Bailly E, Von Tokarski F, Beau-Salinas F, Picon L, Miquelestorena-Standley E, Rousseau G, Jonville-Bera AP, Halimi JM (2018) Interstitial Nephritis Secondary to Vedolizumab Treatment in Crohn Disease and Safe Rechallenge Using Steroids: A Case Report. Am J Kidney Dis, 71(1): 142-5.
3. Bouquet E, Jourdain M, Machet M, Beau-Salinas F, Jonville-Bera AP (2017) Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review. Pediatr Blood Cancer, 64(11): doi: 10.1002/pbc.26597. Epub 2017 Apr 25.
4. Le Moigne M, Bulteau S, Grall-Bronnec M, Gerardin M, Fournier J, Jonville-Bera AP, Jolliet P, Dreno B, Victorri-Vigneau C (2017) Psychiatric disorders, acne and systemic retinoids: comparison of risks. Expert Opin Drug Saf, 16(9): 989-95.
5. Cornillier H, Kervarrec T, Tabareau-Delalande F, Mammou S, Jonville-Bera AP, Machet L (2016) Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab. Eur J Dermatol, 26(6): 614-5.
6. Agier MS, Boivin N, Maruani A, Giraudeau B, Gouraud A, Haramburu F, Jean-Pastor M, Machet L, Jonville-Bera AP (2016) Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database. Br J Dermatol, 175(5): 1067-9.
7. Kaguelidou F, Beau-Salinas F, Jonville-Bera AP, Jacqz-Aigrain E (2016) Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database. Br J Clin Pharmacol, 82(4): 1058-68.
8. Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen L, Bernard N, Vial T, Yates L, Pistelli A, Ellfolk M, Eleftheriou G, de Vries L, Jonville-Bera AP, Kadioglu M, Biollaz J, Buclin T (2016) Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology, 86(24): 2251-7.
9. Nadal M, Giraudeau B, Tavernier E, Jonville-Bera AP, Lorette G, Maruani A (2016) Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review. Acta Derm Venereol, 96(4): 448-52.
10. Marret H, Simon E, Beucher G, Dreyfus M, Gaudineau A, Vayssière C, Lesavre M, Pluchon M, Winer N, Fernandez H, Aubert J, Bejan-Angoulvan T, Jonville-Bera AP, Clouqueur E, Houfflin-Debarge V, Garrigue A, Pierre F, Collège National des Gynécologues Obstétriciens Français (2015) Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français. Eur J Obstet Gynecol Reprod Biol, 187: 80-4.

Chapitres d'ouvrage

1. Damase-Michel C, Jean-Pastor M, Jolliet P, Jonville-Bera AP, Lacroix I, Louvigne C, Parry E (2012) Chapitre 15 – Infectiologie : 15.1 Antibiotiques. . In « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.
2. Louvigne C, Jolliet P, Jonville-Bera AP (2012) Chapitre 20 – Pneumologie. In Participation à un livre : « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.

Articles dans une revue nationale

1. Simon C, Lengellé C, Agier MS, Beau-Salinas F, Vrignaud L, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(11): 1150-7.
2. Alami Z, Agier MS, Ahid S, Vial T, Dautriche A, Lagarce L, Toutain A, Cherrah Y, Jonville-Bera AP (2017) Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study. Therapie: pii: S0040-5957(17)30152-X. doi: 10.1016/j.therap.2017.06.006. [Epub ahead of print].
3. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(9): 906-7.
4. Vrignaud L, Simon C, Agier MS, Bejan-Angoulvant T, Bouquet E, Beau-Salinas F, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(8): 783-7.
5. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(5): 501-6.
6. Agier MS, Marchand S, Paret N, Gautier S, Jonville-Bera AP (2017) [Post-licensure safety surveillance for Prevenar 13® in France]. Arch Pediatr, 24(5): 439-44.
7. Weber E, Moulis G, Mahévas M, Guy C, Lioger B, Durieu I, Hunault M, Ramanantsoa M, Royer B, Default A, Perault-Pochat M, Moachon L, Bernard N, Bardy G, Jonville-Bera AP, Geniaux H, Godeau B, Cathébras P (2017) [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study]. Rev Med Interne, 38(3): 167-75.
8. Agier MS, Beau-Salinas F, Bejan-Angoulvant T, Lengellé C, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(1): 81-6.
9. Agier MS, Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(11): 1204-16.
10. Simon C, Agier MS, Béné J, Muller C, Vrignaud L, Marret H, Jonville-Bera AP (2016) [Safety profile of etonogestrel contraceptive implant (Nexplanon® and Implanon®) reported in France]. J Gynecol Obstet Biol Reprod, 45(9): 1074-82.
11. Agier MS, Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(9): 1002-5.
12. Jonville-Bera AP, Mallaret M, Sgro C, Association Française des Centres Régionaux de Pharmacovigilance (2016) [The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!]. Thérapie, 71(4): 351-4.
13. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Agier MS, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(6): 646-52.
14. Jonville-Bera AP, Vial T, Sgro C, Mallaret M, Association Française des Centres Régionaux de Pharmacovigilance (2016) [On the absence of reimbursement of rotavirus vaccine in France]. Arch Pediatr, 23(6): 655-7.
15. Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(11): 1200-6.
16. Maruani A, Carriot M, Jonville-Bera AP, Lorette G, Gissot V, association Recommandations en Dermatologie (aRED) (2015) [Highlight on clinical research in pediatrics]. Ann Dermatol Venereol, 142(6): 446-9.
17. Bejan-Angoulvant T, Crochet J, Jonville-Bera AP (2015) [Calcium channel blockers pharmacology and their use as tocolytics]. J Gynecol Obstet Biol Reprod, 44(4): 305-11.
18. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(4): 440-6.
19. Bejan-Angoulvant T, Beau-Salinas F, Lengellé C, Cissoko H, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(2): .

Communications scientifiques

Poster dans un colloque national (idpers=1398)

1. Picard S., Leven C., Jonville-Bera A.P., Riche C., Perault-Pochat M., Lainé-Cessac P., Coquerel A., Jolliet P., Renaudineau E. Etude prospective sur les néphropathies immunoallergiques (NIA) médicamenteuses dans 11 unités françaises de néphrologie.9ème Congrès de Physiologie de Pharmacologie et de thérapeutique, Poitiers, 22-24 avril 2014, 2014.